Eclitasertib

CAS No. 2125450-76-0

Eclitasertib( DNL-758 | SAR-443122 )

Catalog No. M28842 CAS No. 2125450-76-0

Eclitasertib is a potent inhibitor of receptor-interacting protein kinase 1 (RIPK1, IC50 of <1 μΜ).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 250 In Stock
2MG 145 In Stock
5MG 227 In Stock
10MG 359 In Stock
25MG 653 In Stock
50MG 886 In Stock
100MG 1265 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Eclitasertib
  • Note
    Research use only, not for human use.
  • Brief Description
    Eclitasertib is a potent inhibitor of receptor-interacting protein kinase 1 (RIPK1, IC50 of <1 μΜ).
  • Description
    Eclitasertib is a potent inhibitor of receptor-interacting protein kinase 1 (RIPK1, IC50 of <1 μΜ).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    DNL-758 | SAR-443122
  • Pathway
    Apoptosis
  • Target
    RIP kinase
  • Recptor
    GLUT
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2125450-76-0
  • Formula Weight
    378.38
  • Molecular Formula
    C19H18N6O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (330.36 mM)
  • SMILES
    CN(c1ncccc1OC[C@@H]1NC(c2nc(Cc3ccccc3)n[nH]2)=O)C1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Liu KG, et al. Discovery and Optimization of Glucose Uptake Inhibitors. J Med Chem. 2020;63(10):5201-5211.
molnova catalog
related products
  • CSLP43

    CSLP43 (RIPK2 inhibitor CSLP43) is a novel potent, ATP pocket-binding RIPK2 inhibitor with IC50 of 19.9 nM in ADPGlo assay.

  • HS-1371

    HS-1371 (HS1371) is a novel potent, ATP-competitive receptor-interacting protein kinase-3 (RIP3 or RIPK3 kinase) inhibitor with IC50 of 20.8 nM.

  • RIPK2-IN-1

    A potent, selective receptor interacting protein-2 (RIP2) kinase inhibitor.